T36.2X4D Poisoning by chloramphenicol group, undetermined, subsequent encounter

Name of the Condition

• Poisoning by chloramphenicol group, undetermined, subsequent encounter

Summary

This condition represents a subsequent encounter for poisoning by chloramphenicol or its derivatives where the intent is undetermined. It applies to cases where exposure leads to harmful effects, and the encounter occurs during the recovery or follow-up phase. Documentation should specify the chloramphenicol agent, undetermined intent, and details of the subsequent encounter.

Causes

Poisoning may result from accidental or intentional exposure to chloramphenicol, though the intent is not confirmed. Underdosing can occur due to dosing errors, non-adherence, or inadequate prescription. Adverse effects may stem from hypersensitivity, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

• Prior history of chloramphenicol allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., bone marrow suppression).
• Neurologic: Dizziness, confusion, altered mental status.

Diagnosis

Evaluation includes patient history of chloramphenicol exposure, clinical assessment of symptoms, and laboratory tests to detect drug levels or toxic effects. Imaging or other studies may be used to rule out complications.

Treatment Options

Management focuses on supportive care, such as fluid resuscitation, monitoring of organ function, and addressing specific symptoms. Antidotes are not typically available, so treatment is symptomatic. Follow-up care may involve monitoring for delayed effects.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and response to treatment. Subsequent encounters require ongoing assessment of recovery, resolution of symptoms, and prevention of recurrence. Follow-up may include repeat testing or clinical evaluations.

Complications

Potential complications include organ damage (e.g., hepatic or renal), prolonged toxicity, or treatment failure due to underdosing. Allergic reactions may progress to anaphylaxis, and systemic effects can lead to long-term impairment.

Lifestyle & Prevention

Patients should be educated on proper medication use, storage, and disposal. Avoiding polypharmacy without supervision and ensuring clear dosing instructions can reduce risks. Regular monitoring for high-risk patients is recommended.

When to Seek Professional Help

Seek immediate care for severe symptoms like difficulty breathing, seizures, or altered mental status. Follow up with a healthcare provider for persistent symptoms or if exposure is suspected, even if initial symptoms are mild.

Tips for Medical Coders

Document the type of chloramphenicol, undetermined intent, and subsequent encounter details. Ensure the encounter is classified as a follow-up visit and that all relevant clinical findings are recorded to support the code.